Intra-Cellular Therapies Inc logo

Intra-Cellular Therapies Inc

$ 53.43 -0.38 (-0.71%) 09:44 AM EST
P/E:
At Loss
P/B:
7.02
Market Cap:
$ 5.09B
Enterprise V:
$ 4.31B
Volume:
43.38K
Avg Vol (2M):
777.61K
Also Trade In:
Volume:
43.38K
Market Cap $:
5.09B
PE Ratio:
At Loss
Avg Vol (2-Month):
777.61K
Enterprise Value $:
4.31B
PB Ratio:
7.02
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Intra-Cellular Therapies Inc
NAICS : 325412 SIC : 2834
430 East 29th Street, New York, NY, USA, 10016
Description
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
Name Current Vs Industry Vs History
Cash-To-Debt 25.28
Equity-to-Asset 0.89
Debt-to-Equity 0.04
Debt-to-EBITDA -0.08
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 30.71
Distress
Grey
Safe
Beneish M-Score -0.9
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 40.08
9-Day RSI 43.82
14-Day RSI 45.85
6-1 Month Momentum % -1
12-1 Month Momentum % 87.67

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.17
Quick Ratio 10.82
Cash Ratio 9.6
Days Inventory 335.9
Days Sales Outstanding 70.41
Days Payable 349.28

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.3

Financials (Next Earnings Date:2022-11-09 Est.)

ITCI's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ITCI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 136.951
EPS (TTM) ($) -3.7
Beta 1.12
Volatility % 46.91
14-Day RSI 45.85
14-Day ATR ($) 3.210547
20-Day SMA ($) 55.4655
12-1 Month Momentum % 87.67
52-Week Range ($) 28.445 - 66
Shares Outstanding (Mil) 94.4

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Intra-Cellular Therapies Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More